SAN DIEGO, Oct. 16, 2025 /PRNewswire/ -- Invetech, a global leader in experience design-led instrument development, is proud to announce its work has been recognized with a prestigious 2025 Australian ...

SAN DIEGO, Oct. 16, 2025 /PRNewswire/ -- Invetech, a global leader in experience design-led instrument development, is proud to announce its work has been recognized with a prestigious 2025 Australian ...

Trenchant BioSystems has signed a nonbinding letter of intent with Invetech to form a strategic alliance aimed at advancing Trenchant’s AutoCell system.

SAN DIEGO, June 27, 2025 /PRNewswire/ -- Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today ...

SAN DIEGO, June 26, 2025 /PRNewswire/ -- Invetech, a global leader in solving complex manufacturing and product development challenges in the advanced therapies and diagnostics markets, today ...

Invetech to design and supply automated production systems for commercialization of autologous cell therapy based on Celyad's cardiopoiesis technology platform SAN DIEGO, Feb. 3, 2016 /PRNewswire/ -- ...

SAN DIEGO, June 21, 2022 /PRNewswire/ -- Invetech launches Korus, a closed system for autologous cell therapies that features elutriation and cell wash using gentle counterflow centrifugation. Korus ...

-- Agreement supporting global development and manufacture of instrument to analyze protein and nucleic acid biomarkers continues multi-year relationship between Invetech and Biocartis. The Evalution™ ...

Invetech, a specialist in instrument development and custom automation, is offering clients a process engineering service to improve workflow efficiency in laboratories. The service employs advanced ...

SAN DIEGO, Oct. 17, 2025 /PRNewswire/ -- Invetech, a global leader in experience design-led instrument development, is proud to announce its work has been recognized with a prestigious 2025 Australian ...